Free Trial
NYSE:QGEN

Qiagen (QGEN) Stock Price, News & Analysis

Qiagen logo
$48.25 +0.12 (+0.25%)
Closing price 07/14/2025 03:59 PM Eastern
Extended Trading
$48.28 +0.03 (+0.07%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Qiagen Stock (NYSE:QGEN)

Key Stats

Today's Range
$47.73
$48.47
50-Day Range
$41.23
$48.59
52-Week Range
$37.63
$49.30
Volume
1.51 million shs
Average Volume
1.21 million shs
Market Capitalization
$10.73 billion
P/E Ratio
120.98
Dividend Yield
0.52%
Price Target
$49.40
Consensus Rating
Hold

Company Overview

Qiagen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

QGEN MarketRank™: 

Qiagen scored higher than 73% of companies evaluated by MarketBeat, and ranked 298th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Qiagen has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 3 buy ratings, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Qiagen has only been the subject of 3 research reports in the past 90 days.

  • Read more about Qiagen's stock forecast and price target.
  • Earnings Growth

    Earnings for Qiagen are expected to grow by 8.85% in the coming year, from $2.26 to $2.46 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Qiagen is 120.98, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Qiagen is 120.98, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.69.

  • Price to Earnings Growth Ratio

    Qiagen has a PEG Ratio of 2.45. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Qiagen has a P/B Ratio of 3.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Qiagen's valuation and earnings.
  • Percentage of Shares Shorted

    2.51% of the float of Qiagen has been sold short.
  • Short Interest Ratio / Days to Cover

    Qiagen has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Qiagen has recently decreased by 4.60%, indicating that investor sentiment is improving.
  • Dividend Yield

    Qiagen has a dividend yield of 0.52%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Qiagen does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Qiagen is 62.50%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Qiagen will have a dividend payout ratio of 10.16% next year. This indicates that Qiagen will be able to sustain or increase its dividend.

  • Read more about Qiagen's dividend.
  • Percentage of Shares Shorted

    2.51% of the float of Qiagen has been sold short.
  • Short Interest Ratio / Days to Cover

    Qiagen has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Qiagen has recently decreased by 4.60%, indicating that investor sentiment is improving.
  • News Sentiment

    Qiagen has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Qiagen this week, compared to 7 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Qiagen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.00% of the stock of Qiagen is held by insiders.

  • Percentage Held by Institutions

    70.00% of the stock of Qiagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Qiagen's insider trading history.
Receive QGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter.

QGEN Stock News Headlines

Analysts Set QIAGEN N.V. (NYSE:QGEN) Target Price at $49.40
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

QGEN Stock Analysis - Frequently Asked Questions

Qiagen's stock was trading at $43.2931 at the beginning of the year. Since then, QGEN stock has increased by 11.5% and is now trading at $48.2510.

Qiagen N.V. (NYSE:QGEN) posted its earnings results on Wednesday, May, 7th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.05. Qiagen's revenue was up 5.2% compared to the same quarter last year.
Read the conference call transcript
.

Qiagen shares split before market open on Wednesday, January 29th 2025.The 36-35 split was announced on Wednesday, January 22nd 2025. The newly issued shares were issued to shareholders after the closing bell on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split.

Top institutional investors of Qiagen include Assenagon Asset Management S.A. (0.01%), Park Avenue Securities LLC (0.01%), Wealth Enhancement Advisory Services LLC and Fulton Bank N.A..

Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Qiagen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and PayPal (PYPL).

Company Calendar

Last Earnings
5/07/2025
Ex-Dividend for 7/10 Dividend
7/02/2025
Record date for 7/10 Dividend
7/03/2025
Dividend Payable
7/10/2025
Today
7/15/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:QGEN
CIK
1015820
Employees
5,765
Year Founded
N/A

Price Target and Rating

High Price Target
$55.00
Low Price Target
$43.00
Potential Upside/Downside
+2.4%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.40
Trailing P/E Ratio
120.98
Forward P/E Ratio
21.35
P/E Growth
2.45
Net Income
$83.59 million
Net Margins
4.68%
Pretax Margin
6.91%
Return on Equity
14.61%
Return on Assets
8.80%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
3.37
Quick Ratio
2.83

Sales & Book Value

Annual Sales
$1.98 billion
Price / Sales
5.42
Cash Flow
$3.21 per share
Price / Cash Flow
15.02
Book Value
$16.05 per share
Price / Book
3.01

Miscellaneous

Outstanding Shares
222,290,000
Free Float
202,285,000
Market Cap
$10.73 billion
Optionable
Optionable
Beta
0.68
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:QGEN) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners